Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis. by Boffetta, P et al.
Children's Health Articles
Risk of Childhood Cancer and Adult Lung Cancer after Childhood Exposure to
Passive Smoke: A Meta-Analysis
Paolo Boffetta,1 Jean Tr6daniel,2 andAntonia Greco3
1'nternational Agency for Research on Cancer, Lyon, France; 2Saint Louis Hospital, Paris, France; 3University of Lyon, Lyon, France
We identified more than 30 studies on the association between exposure. to maternal tobacco
smoke during pregnancy and cancer in childhood. We combined their results in meta-analyses
based on arandom effects model. The results ofthe meta-analyses suggest asmall increase in risk
ofall neoplasms [relative risk (RR) 1.10; 95% confidence interval (CI), 1.03-1.19; based on 12
studies], but not ofspecific neoplasms such as leukemnia (RR 1.05; Cl, 0.82-1.34; 8 studies) and
central nervous system tuimors (RR 1.04; CI, 0.92-1.18; 12 studies). Results for other specfic
neoplasms were sparse, butthe available data.did not suggest a strong association for.anytype of
tumor. No dear evidence ofdose response was present in the studies thatadessd this issue.
The resultsg on exposure to nmaternal tobacco smoke before or after pregacy are too sparse to
allowacondusion. T.heresultsonexposure to patemaltobacco smokesuggest associationwith
brain tumors (RR 1.22; CI, 1.05-1.40; based on 10 studies) and lymphomas (RR 2.08; CI,
1.08-3.98; 4 studies). The data are too sparse for the other neoplasms, although dthe results ofa
few recent large studies are compatible with a weak carcinogenic effect ofpaternal smoke. For
exposure from either maternal or paternal smoke, bias and confounding cannot yet be ruled out.
Furtherstudies are.neededtoconfirm thehypothesis thatparental tobacco smoke, from thefather
in particular, is a risk factor of ildhood cancer. Results on the risk oflung cancer in adulthood
and childhood passive smoking exposure are available from 11 studies: they do not provide evi-
dence ofan increased risk (summary RR 0.91; CI, 0.80-1.05). Key work. chlildhood neoplasms,
lung cancer, meta-analysis, parental smoke, passive smoke. Environ Healt Pepect 108:73-82
(2000). [Online 15 December 1999]
htnp://ehpnetl.niehs.nih.govldocs/2000108p73-82boffra/abstract.tml
Cigarette smoking has been identified as a
major source of preventable morbidity and
premature mortality (1). During the last 15
years, attention has focused on the potential
health effects of passive smoke (2). Passive
smoke is composed oftobacco smoke emitted
from the end of a burning tobacco product
(sidestream smoke) plus the smoke and the
portion ofinhaled (mainstream) smoke that is
exhaled by the smoker. Although the compo-
sitions of mainstream smoke and passive
smoke are not identical, passive smoke seems
to include most of the tobacco combustion
by-products, notably the carcinogens (3,4).
There is evidence that exposure to passive
smoke causes lung cancer (2,5) and ischemic
heart disease (6,71. The effects of passive
smoke on cancers other than lung cancer in
adulthood and on nonneoplastic respiratory
diseases in adults are still a matter of discus-
sion (2,8,9). There is also evidence that pas-
sive smoke is harmful for children. In partic-
ular, passive smoke exposure is causally asso-
ciated with lower respiratory tract infections,
fluid in the middle ear, symptoms of upper
respiratory tract irritation, some reduction in
lung function, additional episodes and
increased severity of symptoms in children
with asthma, and the occurrence ofasthma in
previously asymptomatic children (8).
The potential carcinogenic effect of pas-
sive smoke on children has not been clarified.
Paternal smoking may cause mutations in the
spermatogonia (10). Smoking by either par-
ent may affect the developing fetus transpla-
centally or, subsequently, the developing
child. Studies in animals suggest that some
effects of exposure in early life may not be
apparent until adult life (11).
Our meta-analysis reviews epidemiologic
studies of exposure to passive smoke from
the parents and the subsequent development
of childhood neoplasms and lung cancer.
We selected childhood neoplasms because of
the biologic plausibility from experimental
studies of a carcinogenic effect of passive
smoke, and we selected lung cancer because
it is the adult neoplasm for which the evi-
dence ofa causal role ofpassive smoke expo-
sure is the strongest (2,5).
Methods
We searched the medical literature for epi-
demiologic studies on childhood cancer
because tobacco smoking has in many stud-
ies been recorded as a potential confounder
rather than the primary exposure of interest.
Our search was based on Medline (National
Library of Medicine, Bethesda, MD), recent
reviews (12,13), and reference lists from
papers identified through Medline. We did
not include restrictions on language or year
ofpublication. Most studies were carried out
in Western Europe and North America,
where cigarettes are the most commonly
used tobacco product.
There are problems distinguishing trans-
generational, transplacental, and direct
effects of exposure to passive smoke, i.e.,
between the effects of preconceptional, pre-
natal, and postnatal exposure to tobacco
smoke. Mothers and fathers who smoke dur-
ing pregnancy have usually smoked before
the pregnancy and continue to smoke after
the birth. Moreover, because of the concor-
dance of smoking habits in married couples
(14), children who are exposed to maternal
smoking might also be exposed to paternal
smoking. However, the results in most stud-
ies have been reported on ever paternal and
maternal smoking or on smoking during the
index pregnancy. We combined these
sources of exposure and based our meta-
analysis mainly on these results. Whenever
possible, however, we separated the effect of
preconceptional smoking and of smoking
after the index birth.
We also reviewed the studies oflung can-
cer among nonsmokers, in which the effect
of childhood exposure to passive smoke has
been addressed. In most of these studies, no
distinction is made between preconceptional,
transplacental, and direct smoke exposure. In
several studies, on the other hand, a distinc-
tion is made between exposure to passive
smoke from the mother and the father and,
in some cases, other adults.
From the available studies, we extracted
the characteristics ofthe study design and the
results on risk from any exposure to maternal
or paternal smoking during pregnancy, as
well as quantitative results, expressed as the
number of cigarettes per day smoked by the
parents, which was the quantitative variable
more frequently reported. For neoplasms and
groups ofneoplasms for which risk estimates
were available from at least three different
studies, we combined the relative risks (RRs)
for any exposure to tobacco smoke into a
meta-analysis based on a random effects
model (15). We chose the random effects
approach because of the heterogeneity of
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results within some of the subsets of studies.
When no single risk estimate was available
from a study (e.g., results were only available
for different subtypes of a neoplasm or for
different levels of smoking), we first com-
bined the results of each study to derive a
summary risk estimate. In some cases, we
derived the RR and the 95% confidence
interval (CI) from the raw data reported. The
meta-analysis was not weighted for quality
factors; however, we conducted additional
analyses after excluding studies with possible
methodologic deficiencies (e.g., low response
rate). We tested for the presence of publica-
tion bias by looking at the regression of the
logarithm ofthe RR against the inverse ofits
variance. If no publication bias is present,
the RR of each study is independent from
its statistical power, and the slope of the
regression is zero (16). We used ad hoc SAS
programs (SAS Institute, Inc., Cary, NC)
developed by the authors for this analysis.
Results
Childhood Cancer
Ever exposure to maternal tobacco smoke or
exposure duringpregnancy. Four cohort
studies have been published on cancer risks
in the children of mothers who smoked dur-
ing pregnancy (Table 1). Neutel and Buck
(17) reported the results of a prospective
study ofthe relationship between smoking in
pregnancy and cancer in 89,302 newborns
from Ontario, Canada, England, and Wales.
For cancer ofall sites, the children ofsmokers
had an RR of 1.3 (CI, 0.8-2.2). This weak
excess was accounted for by leukemia (RR
1.8) and by solid tumors of sites other than
the nervous system (RR 1.5). No evidence
was present for a dose-response relationship
with the amount ofmaternal smoking.
A signiflcant positive association was
found in a study based on 16,193 infants
born in Great Britain during 1 week in 1970
(18). Thirty-three of these children devel-
oped cancer by 10 years of age; 9 of them
had leukemia. The RR associated with the
mother smoking 2 5 cigarettes/day through-
out the pregnancy, as compared to not
smoking or to smoking < 5 cigarettes/day,
was 2.5 (CI, 1.2-5.1).
In the largest cohort study, from
Sweden, there was no increase in the overall
Table 1. Cohort studies of exposure to maternal smoke during pregnancy and childhood cancer.
First Country, Study size, Factors
author, period of years of Case Exposure adjusted
year (ref) diagnosis follow-up ascertainment assessment Cancer n RR (Cl) for
Neutel, Canada and 89,302 DC Maternal smoking in All 64 1.3(0.8-2.2) None
1971 (17) UK, 1959-1968 7-10 years pregnancy, MR
Golding, UK, 1970-1980 16,193 CR, H Mother smoking . 5 cigarettes All 33 2.5(1.2-5.1) MA, P, S
1990(18) 0-10 years per day in pregnancy, PI
Pershagen Sweden, 497,051 CR Mother smoking in pregnancy, All 327 1.0(0.8-1.3) AC, R, P,
1992(19 1982-1987 0-5years MR Solid tumors 198 1.0(0.7-1.3) M
Central nervous system 81 1.0(0.6-1.6)
Lymphatic and 129 1.0 (0.7-1.5)
hematopoietic system
Klebanoff, Us, 54,795 A Maternal smoking in All 51 0.7 (0.4-1.2) MA
1996(20) 1959-1974 0-8 years pregnancy, PI Leukemia 17 0.8(0.3-2.1)
Abbreviations: A, active follow-up; AC, age of child; CR, cancer registry; DC, death certificates; H, hospital records; MA, maternal age; MR, medical records; P, parity; PI, personal inter-
view; R, residence; ref, reference; S, social class; UK, United Kingdom; US, United States.
Table 2. Case-control studies of exposure totobacco smoke from the mother during pregnancy and overall risk of cancer in childhood.
First Age, Response
author, Country, source of rate (% ) Exposure No. cases/ Maternal Factors
year (ref) time period cases cases/controls assessment controls smoking RR (Cl) adjusted for
Buckley, US and Canada, NR, 100/100 PD 1,814/720 1-9 cpd 1.3)0.9-1.9) AC, MA, R,
1986 (21) 1983-1986 H > 10 cpd 1.0 (0.8-1.2) S
McKinney, UK, 0-14 years, NR NR 555/1,110 1-10 cpd 1.1 (0.8-1.5) NR
1986(22) NR H 211 cpd 0.8(0.6-1.1)
Stjernfeldt, Sweden, 0-16 years, >95/>95 SQ 305/340a 1-9 cpd 1.1 [0.6-1.8]b
1986(23) 1978-1981 H 210 cpd 1.6 [1.1-2.3] None
Forsberg, Sweden, NR, NR MR 69/139 Any smoking 1.1 (0.6-1.9) AC, MA, P
1990(24) 1973-1984 CR
John, US, 0-14 years, 71/63 T 223/196 Anysmoking 1.3(0.7-2.1) AC, G, R
1991 (25) 1976-1983 CR
Golding, UK, NR, NR MR 195/558 Any smoking 1.2 (0.8-1.8) C
1992 (26) 1971-1991 H
Sorahan, UK, 0-15 years, 61/90 PD 1,641/1,641 1-9cpd 1.0(0.7-1.3) AC, G
1995(27) 1977-1981 CR 10-19 cpd 1.2 (1.0-1.4)
20-19 cpd 1.0 (0.8-1.2)
30-39 cpd 0.9(0.6-1.5)
. 40 cpd 1.6 (0.9-3.0)
Sorahan, UK, 0-15 years, 88/60 PQ 1,549/1,549 1-9 cpd 1.0 (0.8-1.2) F, MA, P, S
1997 (28) 1953-1955 CR 10-20 cpd 1.2 (1.0-1.5)
. 21 cpd 1.3 (0.7-2.3)
Abbreviations: AC, age of child; C, calendar period; cpd, cigarettes per day; CR, cancer registry; F, paternal age; G, gender; H, hospitals; MA, maternal age; MR, medical records; NR, not
reported; P, parity; PQ, in-person questionnaire; R, residence; S, social class; SQ, self-administered (postal) questionnaire; T, telephone questionnaire; UK, United Kingdom; US, United
States.
&Diabetic controls. bFigures in square brackets are derived from raw data.
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risk for cancer in children born to mothers
that smoked during the pregnancy (19). The
RRs were similar without any dose-response
relationship for both solid tumors and lym-
phatic and hematopoietic neoplasms. An RR
> 1.5 was found for cancers ofthe endocrine
glands and for myeloid leukemia, reticulosis,
and other lymphatic and hematopoietic neo-
plasms; none of these excesses were statisti-
cally significant. Finally, in a cohort study of
> 50,000 U.S. newborns, no overall associa-
tion or dose-response gradient was found for
all neoplasms or for leukemia (20).
Case-control studies are summarized in
Table 2 (all neoplasms), Table 3 (lymphatic
and hematopoietic neoplasms), Table 4
(nervous system tumors), and Table 5 (other
types ofsolid tumors). In two studies (23,28),
there was evidence of a dose-response rela-
tionship between overall cancer riskin the off-
spring and the number of cigarettes smoked
per day by the mother during pregnancy
(Table 2); the interpretation of one of these
studies (23), however, is limited by the selec-
tion ofchildren with diabetes as controls. In
this study, the increased risk and the linear
trend remained significant only for acute lym-
phocytic leukemia (ALL), accounting for
approximately half of the cases (Table 3).
John and co-workers (25) conducted a
case-control study ofchildhood cancer diag-
nosed in Denver, Colorado. Information on
smoking by both parents and by other house-
hold members was obtained for 223 cases and
196 controls, with a 63% participation rate.
After adjustment for paternal education,
maternal smoking during the first trimester of
pregnancy was associated with an increased
risk for all cancers combined, ALL, and lym-
phomas. In a further large study from the
United Kingdom (27), however, no strong
evidence was provided for a trend with
increasingduration ofsmoking was provided.
No strong association was found between
maternal smoking during pregnancy and
overall childhood cancer in the remaining
case-control studies (21,22,24,26) (Table 2).
McKinney and Stiller (22) reported the
Table 3. Case-control studies of exposure totobacco smoke fromthe mother during pregnancy and risk oflymphatic and hematopoietic neoplasms in childhood.
First Age, Response No.
author, Country, source of rate (%) Exposure cases/ Maternal Factors
year(ref) time period cases cases/controls assessment Neoplasm controls smoking RR (Cl) adjusted for
van Steensel-Moll, Netherlands, 0-14years, 90/69 SQ Lymphohematopoietic 519/507 Any smoking 1.0107-1.3) AC, G, P, S
UK, 0-14 years,
NR H
Italy, 0-14 years,
1974-1984 H
US, 0-14 years,
1976-1983 CR
UK, 0-15 years,
1953-1955 CR
system
PQ Acute lymphocytic
leukemia
Non-Hodgkin lymphoma
NR Leukemia
Lymphoma
SQ Acute lymphocytic
leukemia
Lymphohematopoietic
system
Non-Hodgkin lymphoma
PQ Acute lymphocytic
leukemia
Acute nonlymphocytic
leukemia
Non-Hodgkin lymphoma
T Acute lymphocytic
leukemia
Lymphoma
PQ Lymphohematopoietic
system
PQ, MR Lymphohematopoietic
system
T Leukemia
Acute lymphocytic
leukemia
Acute myeloid leukemia
PQ Acute lymphocytic
leukemia
Myeloid leukemia
Monocytic leukemia
Lymphoma
742/720
169/720
171/1,110
74/1,110
157/340a
185/340a
16/340a
142/307
22/307
19/307
73/196
26/196
14/51
1-9 cpd 1.0(0.6-1.5)
2 10 cpd 0.9 (0.7-1.1)
1-9 cpd 0.8(0.3-1.8)
2 10 cpd 1.0(0.7-1.4)
1-10 cpd 1.0 (0.6-1.7)
2 11 cpd 0.6 (0.4-1.0)
1-10 cpd 1.9(0.9-4.0)
11 cpd 1.0 (0.5-2.0)
1-9 cpd 1.3 [0.7-2.61b
10 cpd [3.41121-5.7]
1-9 cpd [1.31[0.7-2.21
2 10 cpd 1.8 [1.2-2.8]
1-9 cpd [1.4] [0.3-6.71
2 10 cpd 2.1 [0.7-6.41
Any smoking 0.7 (0.5-1.1)
2.0(0.8-4.8)
1.7 (0.7-4.5)
Any smoking 1.9(0.9-4.1)
2.3 (0.8-7.1)
Any smoking 1.0 (0.3-1.4)
AC, MA, R, S
NR
None
S
AC, G, R
AC, G, R
54/324 Any smoking 0.5 (0.2-1.2) AC, G, R
302/558 1-10 cpd
11-20 cpd
.21 cpd
203/558 1-10 cpd
11-20 cpd
.21 cpd
88/558 1-10 cpd
11-20 cpd
21 cpd
367/367 Any smoking
115/115
27/27
125/125
0.7 (0.4-1.0)
0.6 (0.4-1.1)
0.6 (0.2-1.8)
0.8 (0.5-1.3)
0.8 (0.4-1.4)
0.5 (0.1-1.9)
0.5 (0.2-1.3)
0.4 (0.1-1.1)
0.7 (0.1-5.8)
1.2 (1.0-1.5)
1.2 (0.9-1.7)
1.2 (0.6-2.5)
0.8 (0.5-1.1)
Al, E, G, MA
F, MA, P, S
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1973-1980
US and
Canada,
1983-1986
CR
NR
H
Sweden,
1978-1981
0-16 years,
H
1985 (29
Buckley,
1986(21)
McKinney,
1986(22)
Stjernfeldt,
1986 (23)
Magnani,
1990(30)
John,
1991 (25)
Urquhart,
1991 (31)
Roman,
1993 (32)
Shu,
1995 (33)
100/100
NR/NR
>95/>95
NR/NR
71/63
87/84
76/95
79/75
UK,
1968-1986
UK,
1972-1989
US, Canada,
and
Australia,
1983-1988
0-14 years,
CR
0-4 years,
H
0-1.5 years
H
Sorahan,
1997 (28)
88/60
Abbreviations: AC, age of child; Al, alcohol drinking; cpd, cigarettes per day; CR, cancer registry; E, education; F, paternal age; G, gender; H, hospitals; MA, maternal age; MR, medical
records; NR, not reported; P, parity; Q, in-person questionnaire; R, residence; ref, reference; S, social class; SQ, self-administered (postal) questionnaire;T,telephone questionnaire; UK,
United Kingdom; US, United States.
'Diabetic controls. bFigures in square brackets are derived from raw data.
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results from a multicenter English study of
childhood cancer. For each of555 cases, two
age- and sex-matched controls were selected.
There was no evidence of an increased risk
of cancer in the children of mothers who
smoked in pregnancy. Detailed analysis
restricted to leukemia and lymphoma also
failed to show a positive association between
maternal smoking during pregnancy and
increased risk (52) (Table 3). A small
increase in risk of all childhood neoplasms
with no evidence of a dose-response rela-
tionship was reported by Buckley and col-
leagues (21). A slight increase in risk was
associated with maternal smoking during
pregnancy in the two remaining studies
(24,26), one ofwhich, from Sweden, partial-
ly overlapped with the cohort study of
Pershagen et al. (19).
The meta-analysis of the 12 studies that
provided an RR for maternal smoke and
overall cancer risk resulted in a summary RR
of 1.10 (CI, 1.03-1.19). There were no dis-
crepancies among the results of the four
cohort studies (RR 1.15; CI, 0.77-1.72) and
those of the eight case-control studies (RR
1.10; CI, 1.04-1.17). Therewas no evidence
ofpublication bias (p= 0.69).
With respect to lymphatic and hemato-
poietic neoplasms, except in the studies by
Stjernfeldt et al. (23) andJohn et al. (25), no
strong association was found in any study for
leukemia or for leukemia and non-Hodgkin
lymphoma (NHL) combined (Table 3). In a
large UK study, we found no evidence of a
trend in risk oflymphoma or leukemia with
increasing maternal smoking (27). Among
the studies that looked at specific neoplasms,
an Italian study (30) suggested an association
with acute nonlymphocytic leukemia (AnLL)
and NHL. The results of the meta-analysis
were 1.03 (CI, 0.90-1.17) for all lymphatic
and hematopoietic neoplasms (nine studies);
1.13 (CI, 0.85-1.49) for either NHL or all
lymphomas (six studies); and 1.05 (CI,
0.82-1.34) for either all leukemia, acute
leukemia, or ALL (eight studies). There was
evidence of publication bias in the available
results on lymphomas (p = 0.04): studies
with a large number ofcases tended to show
null results (21,28), whereas studies with a
small number ofcases were consistently posi-
tive (23,25,30), leaving open the possibility
that small null or negative studies have not
been reported (Table 3).
No clear association between maternal
smoking during pregnancy and tumors of
Table 4. Case-control studies of exposure totobacco smoke from the motherduring pregnancy and risk of cancer ofthe nervous system in childhood.
First Age, Response Factors
author, Country, source of rate (%) Exposure No. cases/ Maternal adjusted
year (ref) time period cases cases/controls assessment Cancer controls smoking RR (Cl) for
Preston-Martin, US, 0-24 years, 66/78 T Brain 209/209 Anysmoking 1.1 [0.7-1.61a AC
1982(34) 1972-1977 CR
McKinney, UK, 0-14 years, NR/NR NR Central nervous system 78/1,110 1-10cpd 1.1 (0.5-2.4) NR
1986(22) NR H . 11 cpd 1.0(0.5-2.0)
Stjernfeldt, Sweden, 0-16 years, >95/>95 SQ Central nervous system 43/340b 1-9cpd 1.0 [0.4-2.8] None
1986(23) 1978-1981 H >10cpd 0.910.4-2.0]
Kramer, US, NR 75/57 T Neuroblastoma 104/101 Anysmoking 1.3[0.7-2.3] AC, R,
1987(35) 1970-1979 H Ra
Bunin, US, NR 71/78 T Heritable retinoblastoma 67/201 Anysmoking 2.0(0.7-6.5) AC, R,
1989 (36) 1982-1985 H Nonheritable retinoblastoma 115/201 1.1(0.6-2.1) Ra
Howe, Canada, 0-19 years, 60/86 PQ Brain 74/138 Anysmoking 1.4(0.7-3.0) AC
1989(37) 1977-1983 H
Kuijten, US, 0-14 years, 80/73 T Astrocytoma 163/163 Anysmoking 1.0(0.6-1.7) AC, R,
1990(38) 1980-1986 H Ra
John, US, 0-14years, 71/63 T Central nervous system 48/193 Anysmoking 0.7(0.3-1.7) AC, G, R
1991 (25) 1976-1983 CR
Schwartzbaum, US, 0-8 years, 64/68 T Neuroblastoma 101/690C 1-9cpd 1.3(0.4-3.5) NR
1992(39) 1979-1986 H .10cpd 1.7(0.7-2.4)
Gold, US, 0-17 years, 85/85 PQ Brain 322/955 1-19cpd 0.8(0.6-1.3) AC, G,
1993(40) 1977-1981 CR . 20cpd 1.0(0.7-1.4) Ra
Astrocytoma 1-19 cpd 0.7 (0.4-1.4)
220cpd 1.1 (0.7-1.8)
Medulloblastoma 1-19 cpd 1.0(0.4-2.7)
>20cpd 1.1(0.5-2.6)
Bunin, US, 0-5years, 65/83 T Astrocytoma 155/155 Anysmoking 1.0(0.6-1.7)
1994 (41) 1986-1989 H Primary neuroectodermal 166/166 1.0(0.6-1.7)
tumor
Cordier, France, 0-14years, 69/71 PQ Brain 109/113 Anysmoking 1.6(0.7-3.5) AC, E, G,
1994 (42) 1985-1987 H MA
Filippini, Italy, 0-14years, 88/75 PQ Brain 91/321 1-10cpd 1.6(0.7-3.8) AC, E, G,
1994(43) 1985-1988 CR .11 cpd 1.7(0.4-6.6) R
McCredie, Australia, 0-14years, 85/60 PU Brain 82/164 Anysmoking 0.9(0.5-1.8) AC, E, G
1994(44) 1985-1989 CR
Norman, US, 0-14years, NR/NR PQ Brain 540/801 Anysmoking 1.0(0.7-1.3) AC, G,
1995 (45) 1984-1991 CR Ra
Sorahan, UK, 0-15 years, 88/60 PU Central nervous system 229/229 Anysmoking 1.0(0.8-1.3) F, MA, P,
1997 (28) 1953-1955 CR Neuroblastoma 138/138 0.9 (0.7-1.3) S
Abbreviations: AC, age of child; cpd, cigarettes per day; CR, cancer registry; E, education; F, paternal age; G, gender; H, hospitals; 1, income; M, maternal age; NA, not available; NR, not
reported; P,parity;PQ, in-person questionnaire; R, residence; Ra, race; S, social class; SQ,self-administered (postal)questionnaire;T,telephone questionnaire; UK, United Kingdom; US,
United States.
"Figures in square brackets are derived from raw data. bDiabetic controls. cCancer controls (mainly acutelymphocytic leukemia).
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either the central nervous system (CNS) or
the brain has been found in most studies
that addressed this association (Table 4):
positive and negative results tend to balance.
The summary RR estimated via the meta-
analysis was 1.04 (CI, 0.92-1.18; 12 stud-
ies), with no evidence of publication bias.
An additional UKstudy that assessed the lin-
ear trend in brain cancer risk with increased
maternal smoking reported no association
(27). When specific tumors ofthe CNS were
considered, a positive association with neu-
roblastoma was found in an American study
(39), whereas two other neuroblastoma stud-
ies did not confirm this finding (28,35). The
meta-analysis of these three studies yielded
an RR of 1.25 (CI, 0.78-2.00). The only
available study of retinoblastoma found a
nonsignificant increase in risk from maternal
smoking for the heritable form but not for
the nonheritable form (36).
No association between Ewing sarcoma
and maternal smoking during pregnancy was
suggested in the two fully reported studies in
which this neoplasm was assessed (49,50)
(Table 5). However, in a study reported only
in abstract form (53), a positive association
was found for smoking ofboth parents.
There was no association between mater-
nal smoking during pregnancy and either kid-
neycancerorWilms tumor (21-23,27,28,51),
hepatoblastoma (46), bone cancer (27,28),
rhabdomyosarcoma (47,48), or soft-tissue
sarcomas in general (25,47) (Table 5). In
one of the three dose-response studies of
Wilms tumor (23), the risk increased with
an increased amount of maternal smoking.
The meta-analysis results for kidney cancer
or Wilms tumor were 0.95 (CI, 0.76-1.19;
five studies).
Exposure to maternal tobacco smoke
before pregnancy. Three studies of brain
neoplasms reported results separately for
maternal smoking before and during the
index pregnancy (25,44,45). The odds ratios
(ORs) were 0.9 (CI, 0.4-2.1) (25); 0.4 (CI,
0.1-1.3) (44); and 0.8 (CI, 0.6-1.0) (45).
One of these studies also reported results
from preconceptional exposure to maternal
smoke for other neoplasms (25): lymphomas
(OR 1.9; CI, 0.7-5.2), ALL (OR 2.1; CI,
1.0-4.3), and soft-tissue sarcomas (OR 1.2;
CI, 0.5-3.0). For the three neoplasms, the
risks are similar to those estimated for expo-
sure during pregnancy (Tables 3 and 5). The
ORofleukemia from maternal smoke before
the index pregnancy was reported in two
additional studies as 1.0 (CI, 0.8-1.3) (291
and 0.7 (CI, 0.5-1.0) (33).
Exposure to maternaltobacco smokeafter
pregnancy. No risk estimates were reported
on the risk of childhood cancer from expo-
sure to maternal smoke after birth as distin-
guished from in utero or preconceptional
exposure. Several of the studies reviewed in
"Ever Exposure to Maternal Tobacco Smoke
or Exposure during Pregnancy" assessed ever
smoking status of the mother, which likely
includes mothers smoking before, during,
and after the index pregnancy. However,
these studies are not relevant to assess the
effect ofpassive smoke exposure during preg-
nancy for that of transplacental exposure to
tobacco components and metabolites.
Maternal exposure to spousal passive
smoking. The risk of brain cancer in non-
smoking mothers exposed to the smoke of
their husbands was investigated in one study
in Italy (43). The RR for any exposure dur-
ing pregnancy was 1.9 (CI, 1.0-3.7); when
duration ofexposure was considered, a trend
in risk was suggested: the RR for 1-2 hr/day
was 1.6 (CI, 0.8-3.6), the RR for2 3 hr/day
was 2.1 (CI, 1.0-4.4).
Exposure topaternal tobacco smoke. The
cancer risk in children after exposure to
tobacco smoke from their father has been
addressed in fewer studies than exposure
from their mother. These studies are sum-
marized in Table 6.
In an early study, Stewart and colleagues
(55) found that only a slightly higher pro-
portion offathers ofchildren with childhood
cancer of any type were smokers as com-
pared to fathers of control children (no
detailed results provided). A recent study
Table 5. Case-control studies of exposure to tobacco smoke from the mother during pregnancy and risk of solid tumors other than cancer of the nervous system
in childhood.
First Age, Response Factors
author, Country, source of rate (%) Exposure No. cases/ Maternal adjusted
year (ref) time period cases cases/controls assessment Cancer controls smoking RR (Cl) for
Buckley, US and Canada, NR, 100/100 PQ Kidney 61/720 1-9 cpd 1.6(0.6-4.2) AC, MA,
1986 (21) 1983-1986 H 2 10 cpd 0.9(0.5-1.8) R, S
McKinney, UK, 0-14 years, NR/NR NR Wilmstumor 32/1,110 1-10cpd 0.9(0.3-2.6) NR
1986(22) NR H .11 cpd 1.2(0.4-3.5)
Stjernfeldt, Sweden, 0-16 years, >95/>95 SQ Kidney 16/340a 1-9 cpd 0.7 [01-5.6]b None
1986(23) 1978-1981 H 2 10 cpd 2.5 [0.9-7.2]
Buckely, US, NR, 63/NR T Hepatoblastoma 75/75 1-9 cpd 2.6 (NA) AC
1989(46) 1980-1983 H 10-19cpd 0.8(NA)
220cpd 1.2(NA)
Magnani, Italy, NR, NR PQ All soft-tissue sarcomas 52/326 1-15 cpd 1.0(0.4-2.4) S
1989(47) 1983-1984 H Rhabdomiosarcoma 36/326 2 16 cpd 0.8(0.4-2.0)
1-15 cpd 0.7(0.3-2.0)
2 16 cpd 0.8 (0.4-1.8)
Grufferman, US, NR, NR NR Rhabdomiosarcoma 322/322 Any smoking 1.0(0.8-1.4) NR
1991 (48) NR H
Holly, US, 7-31 years, 86/84 PQ Ewing sarcoma 43/193 Any smoking 1.1 (0.5-2.4) AC, D,1,
1992(49) 1978-1986 CR,H R
Winn, US, 0-22 years, 76/89 T Ewing sarcoma 208/208 1-19 cpd 1.3(0.8-2.7) AC, G, R,
1992(50) 1983-1985 H 2 20 1.4(0.8-2.6) Ra
Olshan, US, 0-14 years, 61/52 SQ Wilms tumor 200/233 1-9 cpd 0.8(0.3-1.8) AC,R
1993 (51) 1984-1986 H 2 10 cpd 0.7 (0.4-1.3)
Sorahan, UK, 0-15 years, 88/60 PQ Wilms tumor 133/133 Any smoking 1.0 (0.7-1.4) F, MA, P,
1997(28) 1953-1955 CR Bone cancer 22/22 0.9(0.4-2.0) S
Abbreviations: AC, age of child; cpd, cigarettes per day; CR, cancer registry; D, drug use; F, paternal age; H, hospitals; 1, income; MA, maternal age; NA, not available; NR, not reported;
P, parity; PQ, in-person questionnaire; R, residence; ref, reference; S, social class; SQ, self-administered (postal) questionnaire; T, telephone questionnaire; UK, United Kingdom; US,
United States.
8Oiabetic controls. bFigures in square brackets are derived from raw data.
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from the United Kingdom provided evi-
dence of a dose-response relationship
between the amount of paternal smoking
and the overall childhood cancer risk (27).
In this study, a trend in risk was suggested
for ALL, lymphomas, and brain cancers. In
the study by John et al. (25), 105 children
were exposed to paternal smoking only.
Weak associations with paternal smoking
before birth in the absence of maternal
smoking were found for all cancers com-
bined, ALL, lymphomas, and brain tumors.
A strong association (RR, adjusted for
socioeconomic status, 6.7; CI, 1.0-43)
between NHL and paternal smoking before
the child's birth, without dose-response rela-
tion, was found in an Italian study (30). A
positive association between rhabdomyosar-
coma and the father ever having smoked cig-
arettes was reported in a small study in North
Carolina (54). However, a larger case-control
study did not confirm these results; the cases
comprised 322 children with rhabdomyosar-
coma; the study showed RRs of 1.0 (CI,
0.7-1.4), 1.0 (CI, 0.7-1.4), and 0.9 (CI,
0.7-1.3) for paternal smoking during the
year preceding or at the time of the index
child's diagnosis, after the child's birth, and
at the time ofdiagnosis, respectively (48,56).
In a study of retinoblastoma, a nonsignifi-
cant association was found for the heritable
form but not for the nonheritable form, a
pattern similar to that found for maternal
smoke (36).
In a large and carefully conducted study
from China, an increased risk was found for
lymphomas (OR 4.0; CI, 1.3-13), with a
trend suggested for the average amount of
smoking, the duration of smoking, and the
cumulative consumption [ORs 2.8 (CI,
0.-13), 1.3 (CI, 0.3-5.5), and 5.7 (CI,
1.3-26) for 1-5, 6-10, and > 10 pack-years)
(57). In the same study, a dose response was
suggested for acute leukemia and brain
tumors. Of the numerous other studies of
childhood brain tumors and paternal smok-
ing, only a rather small investigation from
Australia (44) reported a positive association.
We conducted meta-analyses on paternal
smoke and the risk of NHL (RR 2.08; CI,
1.08-3.98; 4 studies), ALL (RR 1.17; CI,
0.96-1.42; 4 studies), and CNS tumors or
brain cancer (RR 1.22; CI, 1.05-1.40; 10
studies). In two studies, there was no clear
evidence of a dose-response relationship
between the amount ofpaternal smoke and
the risk ofALL or lymphoma (33,52). The
pooled risks estimated for ALL, NHL, and
CNS tumors are higher than the correspond-
ing figures estimated for maternal smoke.
There was no evidence of publication bias
for any ofthe three neoplasms analyzed with
respect to paternal smoke.
Table 6. Case-control studies of exposure totobacco smoke from the fatherduring pregnancy and risk ofneoplasms in childhood.
First Age, Response Factors
author, Country, source of rate (%l Exposure No. cases/ Maternal adjusted
year (ref) time period cases cases/controls assessment Cancer controls smoking RR (CI) for
Grufferman, us, 0-14 years, 89/73 PQ Rhabdomiosarcoma 33/99 Anysmoking 3.9 (1.5-9.6) AC, G, Ra
1982 (54) 1967-1976 H
Preston-Martin, US, 0-24years, 66/78 T Brain 209/209 Anysmoking 1.5[1.0-2.21a AC
1982(34) 1972-1977 CR
Kramer, US, NR, 75/57 T Neuroblastoma 104/101 Anysmoking 1.3 [0.7-2.3] AC,H, Ra
1987(35) 1970-1979 H
Bunin, US, NR, 71/78 T Heritable retinoblastoma 67/201 Anysmoking 2.3 (0.8-7.0) AC, R, Ra
1989(36) 1982-1985 H Nonheritable retinoblastoma 115/201 1.2(0.7-2.3)
Howe, Canada, 0-19 years, 60/86 PQ Brain 74/138 Anysmoking 1.1(0.6-2.1) AC
1989(37) 1977-1983 H
Magnani, Italy, 0-14years, NR PQ All soft-tissue sarcomas 52/326 1-15cpd 1.0(0.4-2.3) S
1989(47) 1983-1984 H Rhabdomiosarcoma 52/326 . 16cpd 0(-)
1-15 cpd 0.7 (0.3-1.4)
216cpd 0(-)
Kuijten, US, 0-14years, 80/73 T Brain 163/163 Anysmoking 0.8(0.5-1.3) AC, R, Ra
1990(38) 1980-1986 H
Magnani, Italy, 0-14 years, NR PQ Acutelymphocytic leukemia 142/307 Anysmoking 0.9(0.6-1.5) S
1990(30) 1974-1984 H Acute nonlymphocytic leukemia 22/307 0.9(0.3-2.1)
Non-Hodgkin lymphoma 19/307 6.7 (1.0-43)
Grufferman, US, 0-14 years, NR/NR PQ Rhabdomiosarcoma 322/322 Anysmoking 1.0(0.7-1.4) NR
1991 (48) NR NR
John, US, 0-14 years, 71/63 T Acute lymphocytic leukemia 73/196 Anysmoking 1.4(0.6-3.1) AC, G, R
1991(25) 1976-1983 CR Lymphoma 26/196 1.6(0.5-5.4)
Brain 48/196 1.6(0.7-3.5)
Holly, US, 0-22 years, 76/89 T Ewing sarcoma 208/208 Anysmoking 1.3(0.8-1.9) AC, G, R,
1992 (49) 1983-1985 H Ra
Winn, US, 7-31 years, 86/84 PQ Ewing sarcoma 43/193 Anysmoking 0.9(0.4-1.9) AC, D, I, R
1992(50) 1978-1986 CR,H
Gold, US, 0-17 years, 85/85 PQ Brain 322/955 1-19cpd 0.7(0.4-1.2) AC, G, Ra
1993(40) 1977-1981 CR 220cpd 1.1 (0.8-1.5)
Astrocytoma 148/531 1-19 cpd 0.5(0.2-1.2)
220cpd 1.1 (0.7-1.8)
Medulloblastoma 56/159 1-19 cpd 1.6(0.5-5.6)
. 20 cpd 1.1(0.5-2.3)
Olshan, US, 0-14 years, 61/52 SQ Wilms tumor 200/233 1-9cpd 0.5(0.1-1.6) AC, R
1993(51) 1984-1986 H . 10 cpd 1.1 (0.7-1.8)
Bunin, US, Canada, 0-5 years, 65/83 T Astrocytoma 155/321 Any smoking 1.0(0.6-1.7)
1994(41) 1986-1989 H Primary neuroectodermal tumor 166/321 1.0 (0.6-1.7)
continued, nextpage
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Results have been reported for exposure
to paternal smoke before and after the index
pregnancy for only one study (57). A signifi-
cant dose response was found among pack-
years ofcigarettes smoked before conception
and risk of all childhood cancers, acute
leukemia, and ALL, whereas a nonsignifi-
cantly increasing trend was found for AnLL,
lymphomas, and brain tumors. The analysis
ofpack-years smoked by the father after the
index birth was not associated with the risk
of all childhood cancers, acute leukemia,
AnLL, or brain tumors, but a nonsignifi-
cantly increasing trend was present for ALL
and lymphomas.
Modification ofthe effect ofparental
smoking byageatdiagnosis. It is possible that
preconceptional or in utero exposure to tobac-
co smoking exerts a stronger carcinogenic
effect during the first years of life ofthe chil-
dren, after which postnatal environmental
exposures might become more relevant. The
available studies, however, offer only limited
evidence in favor of or against this hypothe-
sis. The studies restricted to children
younger than 5 years of age (19,32,41) are
not more supportive of an association
between maternal or paternal smoking and
childhood cancer than other studies. A
study of neuroblastoma was restricted to
children younger than 9 years ofage at diag-
nosis: a separate analysis of the cases diag-
nosed during the first year oflife resulted in
a lower risk estimate than in the entire series
of cases (39). However, cancer controls
(mainly leukemia cases) were used in this
study. In a large study of paternal smoking
from China, an analysis by age at diagnosis
was presented for all neoplasms combined
(57). The risk estimates were higher for
various indicators of paternal smoking
among cases and controls younger than
5 years of age than among older children.
Furthermore, a study of leukemia among
children younger than 18 months of age
reported an association with paternal but
not with maternal smoke (33).
Lung Cancer
Eleven studies of nonsmokers have reported
results on lung cancer after childhood pas-
sive smoke exposure (Table 7). A nonsignifi-
cantly increased risk for ever childhood
exposure was reported in a study from Hong
Kong (58), two studies from the United
States (61,64), and among women in a fur-
ther U.S. study (66). The meta-analysis ofthe
results, based on 10 studies, provides a sum-
mary risk estimate of0.91 (CI, 0.80-1.05). A
few studies provided results separately for
exposure to passive smoke from the mother
and the father (Table 7): the summary risk
estimates were 0.83 (CI, 0.72-0.95) for
Table 6. Continued.
First Age, Response Factors
author, Country, source of rate (%) Exposure No. cases/ Maternal adjusted
year (ref) time period cases cases/controls assessment Cancer controls smoking RR (Cl) for
Filippini, Italy, 0-14 years, 88/75 PQ Brain 91/321 Any smoking 1.3(0.8-2.2) AC, E, G,
1994(43) 1985-1988 CR R
McCredie, Australia, 0-14 years, 85/60 PQ Brain 82/164 Any smoking 2.2(1.2-3.8) AC, E, G
1994(44) 1985-1989 CR
Sorahan, UK, 0-15 years, 61/90 PQ All 1,641/1,641 1-9 cpd 1.2(0.8-1.9) AC, G
1995(27) 1977-1981 CR 10-19 cpd 1.2(0.9-1.5)
20-29 cpd 1.2(1.0-1.5)
30-39 cpd 1.3(1.0-1.7)
240cpd 1.4(1.0-1.9)
Norman, US, 0-14years, 71/74 PQ Brain 540/801 Any smoking 1.2(0.9-1.5) AC, G, Ra
1996(45) 1984-1991 CR
Shu, US, Canada, 0-1.5 years, 79/75 T Leukemia 302/558 1-10 cpd 1.4 (0.7-2.8) Al, E, F, G
1996 (33) Australia, H 11-20cpd 1.1 (0.7-1.8)
1983-1988 .21 cpd 1.4(0.8-2.3)
Acute lymphocytic leukemia 203/558 1-10 cpd 2.4(1.0-5.7)
11-20 cpd 1.3(0.8-2.3)
. 21 cpd 1.5(0.8-2.8)
Acute myeloid leukemia 88/558 1-10 cpd 0.4(0.1-1.9)
11-20 cpd 0.7 (0.3-1.9)
. 21 cpd 1.3(0.4-3.7)
Ji, China, 0-14 years, 83/100 PQ All 642/642 1-9cpd 1.5(1.1-2.3) AC, Al,
1997 (57) 1981-1991 CR 10-14 cpd 1.1 (0.8-1.6) B, E, G,
2 15 cpd 1.5(1.0-2.3) I, MA
Acute leukemia 166/166 1-9 cpd 1.6(0.7-3.9)
10-14 cpd 0.9(0.4-1.5)
2 15 cpd 1.9(0.8-4.6)
Lymphoma 87/87 1-9 cpd 3.4(0.8-14)
10-14 cpd 1.1 (0.3-4.8)
2 15 cpd 3.8(0.9-17)
Brain 107/107 1-9 cpd 1.5(0.5-4.5)
10-14 cpd 1.6(0.6-4.7)
2 15 cpd 2.1 (0.6-8.1)
Sorahan, UK, 0-15 years, 88/60 PQ Acute lymphocytic leukemia 367/367 Any smoking 1.1(0.9-1.3) F, MA, P,
1997 (28) 1953-1955 CR Myeloid leukemia 115/115 1.0 (0.7-1.3) S
Lymphoma 125/125 1.4(1.0-1.8)
Wilmstumor 133/133 1.0 (0.8-1.3)
Bone 22/22 1.5(0.7-3.1)
Central nervous system 229/229 1.2(1.0-1.5)
Abbreviations: AC, age of child; Al, alcohol drinking; B, body mass index; cpd, cigarettes per day; CR, cancer registry; D, drug use; E, education; F, paternal age; G, gender; H, hospitals;
1, income; NR, not reported; MA, maternal age; P, parity; PQ, in-person questionnaire; R, residence; Ra, race; ref, reference; S, social class; SQ, self-administered (postal) questionnaire;
T,telephone questionnaire; UK, United Kingdom; US, United States.
8Figures in square brackets are derived from raw data.
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paternal exposure and 0.99 (CI, 0.78-1.26)
for maternal exposure.
Results oflung cancer risk from quantita-
tive passive smoke exposure (assessed either as
smoker-years or pack-years) have been report-
ed in six of the studies listed in Table 7. In
twoAmerican studies, riskestimates increased
with increasing estimated exposure (61,64),
whereas the remainingstudies did notprovide
evidence ofa positive dose-response relation-
ship (63,65-674. Nodifference in riskaccord-
ing to histologic type of lung cancer was
reported in thetwolargest studies (65,64.
Discussion
The available evidence indicates that the
association between exposure to tobacco
smoke and cancer in children, ifany, is likely
to be weak. The results ofthe meta-analyses
suggested an increased risk ofapproximately
10% after exposure to maternal smoke.
However, despite the fact that the results of
some of the meta-analyses are statistically
significant, several arguments caution against
the conclusion that a causal association has
been established.
The increase in risk is small and is not
clearly concentrated in any specific neo-
plasm: The only neoplasm for which the
result of the meta-analysis on exposure to
maternal smoke is significant is leukemia,
although this may be due to the greater size
ofthe studies involved.
An increase ofthis magnitude can be eas-
ily explained by bias and confounding.
Selection bias is unlikely to represent a major
problem because, although not all the avail-
able studies were population based, there was
no obvious cluster ofpositive results among
cohort studies, hospital-based case-control
studies, or population-based case-control
studies. Publication or reporting bias is a
form ofselection bias that might affect meta-
analyses. The test we used to assess the pres-
ence ofpublication bias (16) is not powerful
when the meta-analysis is based on relatively
few studies, as in the case of neuroblastoma
and exposure to maternal smoke or NHL
and paternal smoke. However, with the
exception of studies of risk of lymphoma
from maternal smoking, we found no strong
evidence ofpublication bias. As an example,
Figure 1 shows the logarithms of the RRs
and the weights (inverse of the variance of
the relative risks) ofthe 12 studies on CNS
cancer and maternal smoke. The pattern does
not suggest a lack ofsmall studies with either
positive or negative results.
Information bias might be a serious prob-
lem for the studies that we reviewed, particu-
larly in the form of recall bias. Accuracy of
recall is crucial in studies ofchildhood can-
cer. Mothers of children with cancer might
be more prone to remember possible noxious
events during pregnancy than mothers of
healthy children. Information on smoking
status ofthe mother was not validated in any
study. Some authors addressed this limitation
by choosing as controls a group ofchildren
with serious diseases, such as other types of
cancer, because their mothers may be expect-
ed to recall past exposures to noxious agents
as vigorously as those of the group of cases
(23,69). However, using cancer controls
potentially eliminates interviewer and recall
bias but may underestimate the RR if both
cancer cases and cancer controls share risk
factors (70).
Confounding factors, i.e., exposures that
related to tobacco smoke exposure and are
also independent risk factors for childhood
cancer, may be responsible for the overall
increased risk. Factors that have been associ-
ated with childhood cancers include drugs
and chemicals (35), parental occupational
exposures (71-73), prenatal exposure to ion-
izing radiation (74), diet (75), and socioeco-
nomic status (76). With the exception of
social class, these factors were not taken into
account in most of the available studies on
parental smoke (Tables 1-6). It is not possi-
ble to determine whether this had any
Table 7. Studies of childhood exposure to passive smoke and lung cancer.
Firstauthor, No. Smoking RR (Cl)
year(ref) Country Sex cases/controls Paternal Maternal Any person
Koo, 1987(58) Hong Kong F 88/137 - - 2.1 (0.5-95)
Pershagen, 1987 (59) Sweden F 77/B _ _ 1.0(0.4-2.3)
Shimizu, 1988(60) Japan F 90/90 1.1 (NAb) 4.0(NAb)
Janerich, 1990 (61) US M, F 191/191 - - [1.5(0.8-2.8)Ic
Sobue, 1990(62) Japan F 144/713 0.8(0.5-1.2) 1.3(0.7-2.3)
Brownson, 1992(63) US F 432/1,402 - - 0.7 (0.5-0.9)
Stockwell, 1992(64) US F 210/301 1.2 (0.6-2.3) 1.6(0.6-4.3)
Fontham, 1994(65) US F 653/1,253 0.8(0.7-1.2) 0.9(0.6-1.2) 0.9(0.7-1.1)
Kabat, 1995(66) US M 41/117 - - 0.9(0.4-1.9)
F 69/187 - - 1.5(0.9-2.8)
Boffetta, 1998(6) 7 countries M, F 650/1,542 0.8(0.6-0.9) 0.9(0.5-1.5) 0.8(0.6-1.0)
Zaridze, 1998(68) Russia F 189/358 0.9(0.6-1.3)
Abbreviations: F,female; M, male; ref, reference; US, United States.
"Cohortstudy. bExcluded from the meta-analysis. cFigures in square brackets are derived from raw data.
impact on the results because their associa-
tion with smoking is unclear (12). However,
confounding remains a plausible explanation
for the observed increased risk.
Despite the fact that some ofthe studies
included in this meta-analysis had a relative-
ly low response rate or collected information
from proxies, no clear pattern emerged on
results on childhood cancer risk, which
might be explained by bias from the lack
ofresponse.
The overall interpretation of the studies
we reviewed is hampered by the crude expo-
sure assessment used. The exposure assess-
ment was often based on a dichotomous
indicator ofsmoking by the parents without
considering quantitative exposure variables.
Most ofthe studies that reported results for
different exposure levels did not provide evi-
dence ofa dose-response relationship, which
also detracts from a causal interpretation of
the summaryriskestimates.
The biologic plausibility of the associa-
tion between tobacco smoke exposure and
childhood cancer is of particular interest
because the types ofcancer in childhood are
different from those of cancers occurring in
adults. Epithelial involvement is relatively
rare in childhood tumors, whereas many of
the tumors have features that recall fetal
development and therefore are embryonal
(77). Involuntary smoking is accompanied by
exposure to manyofthe toxic agents generat-
ed by tobacco combustion, and the intake of
tobacco smoke components-including car-
cinogens and mutagens-by children has
been confirmed in biochemical studies ofcig-
arette smoke during both gestation and
childhood (78-80). Although the conven-
tional assay of cytogenetic abnormalities,
such as chromosome aberrations and sister-
chromatid exchanges, are unable to detect the
low exposures of transplacentally exposed
newborn children (81), activation of procar-
cinogens in human fetal and placental tissues
has been shown (82), as has smoke-induced
damage to DNAin human placenta (83,84).
Transplacental exposures to carcinogens
can cause cancer in humans, as shown by the
occurrence ofvaginal clear-cell adenocarci-
noma in women whose mothers received
diethylstilbestrol during pregnancy (85).
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Figure 1. Funnel plot of results of studies on CNS
cancer and maternal smoking.
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Animals appear to be especially susceptible
to the carcinogenic effects of some of the
chemicals found in tobacco smoke when
exposure is transplacental (86). Moreover,
the exposure ofrodents to chemical carcino-
gens during pregnancy may result not only
in a high incidence oftumors in progeny of
the first generation, but also in an increased
tumor incidence in those of subsequent
generations (87).
The comparison of the results of the
meta-analyses conducted on exposure to
maternal and paternal smoke is problematic.
The evidence for maternal smoke points to a
possible weak effect on lymphatic and
hematopoietic organs. This possible weak
effect is confirmed by the results on paternal
smoke, despite the lack of statistical signifi-
cance of hematopoietic effects. We found
evidence of little or no effect of maternal
smoke on kidney and CNS tumors, although
the results on paternal smoke suggest an
effect on NHLand CNS tumors. This differ-
ence in target organs, which must be con-
firmed, might be related to the different
mechanism of action of carcinogens in
maternal smoke (direct transplacental effects)
and in paternal smoke (mainly via precon-
ceptional alterations). The available evidence
is inadequate to dearly distinguish among an
effect of preconceptional exposure to mater-
nal smoke, in utero exposure, and postnatal
smoke exposure. Two large studies from the
United Kingdom and China, however, sug-
gest that the father's preconceptional smok-
ing can contribute to the risk of some neo-
plasms in offspring (27,57).
Available evidence on the risk of lung
cancer in adulthood after childhood passive
smoke exposure points to the absence of an
increase in risk. The presence ofa few posi-
tive studies, some of which also reported a
positive dose-response relationship, howev-
er, suggests caution in concluding that pas-
sive smoke exposure in childhood is not
related to subsequent risk oflung cancer.
The harmful effects of active smoking
during pregnancy (88), as well as the conse-
quences of passive smoke exposure on
children's respiratory health (8), are well
established. Apart from lung cancer (5,8) and
ischemic heart disease (6,7), the other poten-
tial health consequences of tobacco smoke
exposure have been less extensively investigat-
ed. Overall, there is a suggestion of a weak
association between exposure to tobacco
smoke from the parents, and the father in
particular, and childhood cancer. Bias and
confounding, however, cannot be ruled out
at this stage. Further studies are needed to
overcome the practical difficulties ofidentify-
ing adequate numbers of cases for these rare
diseases and the possible limitations of the
available epidemiologic investigations.
REFERENCES AND NOTES
1. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Doll R.
Mortality from smoking worldwide. Br Med Bull 52:12-21
(1996).
2. Law MR, Hackshaw AK. Environmental tobacco smoke.
Br Med Bull 52:22-34 (1996).
3. O'Neill IK, Brunnemann KD, Dodet B, Hoffman D, eds.
Environmental carcinogens: methods of analysis and
exposure measurement. Volume 9: passive smoking.
IARC Sci Publ 81 (1987).
4. Lofroth G. Environmental tobacco smoke: overview of
chemical composition and genotoxic components. Mutat
Res 222:73-80 (1989).
5. Hackshaw AK, Law MR, Wald NJ. The accumulated evi-
dence on lung cancer and environmental tobacco
smoke. Br Med J 315:980-988 (1997).
6. Steenland K. Passive smoking and the risk of heart dis-
ease. JAMA 267:94-99 (1992).
7. Law MR, Morris JK, Wald NJ. Environmental tobacco
smoke exposure and ischaemic heart disease: an evalu-
ation ofthe evidence. Br Med J 315:973-980 (1997).
8. U.S. EPA. Respiratory Health Effects of Passive Smoking:
Lung Cancer and Other Disorders. EPA/600/6-90/006F.
Washington, DC:U.S. Environmental Protection Agency,
Office of Research and Development, 1992.
9. Tredaniel J, Boffetta P, Saracci R, Hirsch A. Exposure to
environmental tobacco smoke and adult non-neoplastic
respiratory diseases. Eur Respir J 7:173-185 (1994).
10. Evans HJ, Fletcher J, Torrance M, Hargreave TB. Sperm
abnormalities and cigarette smoking. Lancet 1:627-629
(1981).
11. Draper GJ. General overview of studies of multigenera-
tion carcinogenesis in man, particularly in relation to
exposure to chemicals. IARC Sci Publ 96:275-288
(1989).
12. Tredaniel J, Boffetta P, Little J, Saracci R, Hirsch A.
Exposure to passive smoking during pregnancy and
childhood, and cancer risk: the epidemiological evi-
dence. Paediatr Perinat Epidemiol 8:233-255 (1994).
13. Norman MA, Holly EA, Preston-Martin S. Childhood brain
tumours and exposure to tobacco smoke. Cancer
Epidemiol Biomark Prev 5:85-91 (1996).
14. Lee PN. Lung cancer and passive smoking: association
and artefact due to misclassification of smoking habits?
Toxicol Lett 35:157-162 (1987).
15. DerSimonian R, Laird N. Meta-analysis in clinical trials.
Control Clin Trials 7:177-188 (1986).
16. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in
meta-analysis detected by a simple, graphical test. Br
Med J 315:629-634 (1997).
17. Neutel Cl, Buck C. Effect of smoking during pregnancy
on the risk of cancer in children. J NatI Cancer Inst
47:59-63 (1971).
18. Golding J, Paterson M, Kinlen LJ. Factors associated
with childhood cancer in a national cohort study. Br J
Cancer 62:304-308 (1990).
19. Pershagen G, Ericson A, Otterblad-Olausson P. Maternal
smoking in pregnancy: does it increase the risk of child-
hood cancer? lntJ Epidemiol 21:1-5 (1992).
20. Klebanoff MA, Clemens JD, Read JS. Maternal smoking
during pregnancy and childhood cancer. Am J Epidemiol
144:1028-1033 (1996).
21. Buckley JD, Hobbie WL, Ruccione K, Sather HN, Woods
WG, Hammond GD. Maternal smoking during pregnancy
and the risk of childhood cancer [Letter]. Lancet
2:519-520 (1986).
22. McKinney PA, Stiller CA (for the IRESCC group).
Maternal smoking during pregnancy and the risk of
childhood cancer[Letter]. Lancet 2:519 (1986).
23. Stjernfeldt M, Berglund K, Lindsten J, Ludvigsson J.
Maternal smoking during pregnancy and risk of child-
hood cancer. Lancet 1:1350-1352 (1986).
24. Forsberg JG, Kallen B. Pregnancy and delivery charac-
teristics of women whose infants develop child cancer.
APMIS 98:37-42 (1990).
25. John EM, Savitz DA, Sandier DP. Prenatal exposure to
parents' smoking and childhood cancer. Am J Epidemiol
133:123-132 (1991).
26. Goldging J, Greenwood R, Birmingham K, Mott M.
Childhood cancer, intramuscular vitamin K, and pethi-
dine given during labour. Br Med J 305:341-346 (1992).
27. Sorahan T, Lancashire R, Prior P, Peck I, Stewart A.
Childhood cancer and parental use of alcohol and tobac-
co. Ann Epidemiol 5:354-359 (1995).
28. Sorahan T, Lancashire RJ, Hulten MA, Peck I, Stewart
AM. Childhood cancer and parental use of tobacco:
deaths from 1953 to 1955. BrJ Cancer75:134-138 (1997).
29. van Steensel-Moll HA, Valkenburg HA, Vanderbroucke
JP, van Zanen GE. Are maternal fertility problems related
to childhood leukemia? IntJ Epidemiol 14:555-559 (1985).
30. Magnani C, Pastore G, Luzzatto L, Terracini B. Parental
occupation and other environmental factors in the etiol-
ogy of leukemias and non-Hodgkin's lymphomas in child-
hood: a case-control study. Tumori 76:413-419 (1990).
31. Urquhart JD, Black RJ, Muirhead MJ, Sharp L, Maxwell
M, Eden OB, Jones DA. Case-control study of leukaemia
and non-Hodgkin's lymphoma in children in Caithness
near the Dounreay nuclear installation. Br Med J
302:687-692 (1991).
32. Roman E, Watson A, Beral V, Buckle S, Bull D, Baker K,
Ryder H, Barton C. Case-control study of leukaemia and
non-Hodgkin's lymphoma among children aged 0-4years
living in West Berkshire and North Hampshire health dis-
tricts. Br Med J 306:615-621 (1993).
33. Shu XO, Ross JA, Pendergrass TW, Reaman GH,
Lampkin B, Robison LL. Parental alcohol consumption,
cigarette smoking, and risk of infant leukemia: a
Childrens Cancer Group study. J NatI Cancer Inst
88:24-31 (1996).
34. Preston-Martin S, Yu MC, Benton B, Henderson BE. N-
nitroso compounds and childhood brain tumors: a case-
control study. Cancer Res 42:5240-5245 (1982).
35. Kramer S, Ward E, Meadows AT, Malone KE. Medical
and drug risk factors associated with neuroblastoma: a
case-control study. J NatI Cancer Inst78:797-804 (1987).
36. Bunin GR, Meadows AT, Emanuel BS, Buckley JD,
Woods WG, Hammond GD. Pre- and postconception fac-
tors associated with sporadic heritable and nonheritable
retinoblastoma. Cancer Res 49:5730-5735 (1989).
37. Howe GR, Burch JD, Chiarelli AM, Risch HA, Choi BCK.
An exploratory case-control study of brain tumors in
children. Cancer Res 49:4349-4352 (1989).
38. Kuijten RR, Bunin GR, Nass CC, Meadows AT.
Gestational and familial risk factors for childhood astro-
cytoma: results of a case-control study. Cancer Res
50:2608-2612 (1990).
39. Schwartzbaum JA. Influence of the maternal prenatal
drug consumption on risk of neuroblastoma in the child.
Am J Epidemiol 135:1358-1367 (1992).
40. Gold EB, Leviton A, Lopez R, Gilles FH, Hedley-Whyte ET,
Kolonel LN, Lyon JL, Swanson GM, Weiss NS, West D, et
al. Parental smoking and risk of childhood brain tumors.
Am J Epidemiol 137:620-628 (1993).
41. Bunin GR, Buckley JD, Boesel CP, Rorke LB, Meadows
AT. Risk factors for astrocytic glioma and primitive neu-
roectodermal tumour of the brain in young children: a
report from the Children's Cancer Group. Cancer
Epidemiol Biom Prev 3:197-204 (1994).
42. Cordier S, Iglesias MJ, Le Goaster C, Guyot MM,
Mandereau L, Hemon D. Incidence and risk factors for
childhood brain tumours in the lie de France. Int J
Cancer 59:776-782 (1994).
43. Filippini G, Farinotti M, Lovicu G, Maisonneuve P, Boyle
P. Mothers' active and passive smoking during pregnan-
cy and risk of brain tumours in children. Int J Cancer
57:769-774 (1994).
44. McCredie M, Maisonneuve P, Boyle P. Perinatal and
postnatal risk factors for malignant brain tumours in New
South Wales children. IntJ Cancer 56:11-15 (1994).
45. Norman MA, Holly EA, Ahn DK, Preston-Martin S,
Mueller BA, Bracci PM. Prenatal exposure to tobacco
smoke and childhood brain tumours: results from the
United States West Coast childhood brain tumour study.
Cancer Epidemiol Biomark Prev 5:127-133 (1996).
46. Buckley JD, Sather H, Ruccione K, Rogers PC, Haas JE,
Henderson BE, Hammond GD. A case-control study of
risk factors for hepatoblastoma. A report from the
Childrens Cancer Study Group. Cancer 64:1169-1176
(1989).
47. Magnani C, Pastore G, Luzzatto L, Carli M, Lubrano P,
Teracini B. Risk factors for soft tissue sarcomas in child-
hood: a case-control study. Tumori 75:396-400 (1989).
48. Grufferman S, Gula MJ, Olshan AF, Falletta JM, Buckley
J, Pendergrass TW, Maurer HM. Absence of an associa-
tion between parents' cigarette smoking and risk of
Environmental Health Perspectives * Volume 108, Number 1, January 2000 81Children's Health * Boffetta et al.
rhabdomyosarcoma in their children. Paediatr Perinat
Epidemiol 5:A17 (1991).
49. Holly EA, Aston DA, Ahn DK, Kristiansen JJ. Ewing's
bone sarcoma, paternal occupational exposure, and
otherfactors. Am J Epidemiol 135:122-129 (1992).
50. Winn DM, Li FP, Robison LL, Mulvihill JJ, Daigle AE,
Fraumeni JF Jr. A case-control study of the etiology of
Ewing's sarcoma. Cancer Epidemiol Biomark Prev
1:525-532 (1992).
51. Olshan AF, Breslow NE, Falletta JM, Grufferman S,
Pendergrass T, Robison LL, Waskerwitz M, Woods WG,
Vietti TJ, Hammond GD. Risk factors for Wilms tumor.
Report from the National Wilms Tumor Study. Cancer
72:938-944 (1993).
52. McKinney PA, Cartwright RA, Saiu JM, Mann JR, Stiller
CA, Draper GJ, Hartley AL, Hopton PA, Birch JM,
Waterhouse JA, et al. The inter-regional epidemiological
study of childhood cancer (IRESCC): a case-control
study of aetiological factors in leukaemia and lymphoma.
Arch Dis Child 62:279-287 (1987).
53. Daigle AE. Epidemiologic Study of Etiologic Factors in
Ewing's Sarcoma [Ph.D. Thesis]. Minneapolis, MN:
University of Minnesota, 1986.
54. Grufferman S, Wang HH, Delong ER, Kimm SYS, Deizell
ES, Falletta JM. Environmental factors in the etiology of
rhabdomyosarcoma in childhood. J NatI Cancer Inst
68:107-113(1982).
55. Stewart A, Webb J, Hewitt D. A survey of childhood
malignancies. Br Med J i:1495-1508 (1958).
56. Grufferman S, Schwartz AG, Ruyman FB, Maurer HM.
Parents' use of cocaine and marijuana and increased
risk of rhabdomyosarcoma in their children. Cancer
Causes Control 4:217-224 (1993).
57. Ji BT, Shu XO, Linet MS, Zheng W, Wacholder S, Gao YT,
Ying DM, Jin F. Paternal cigarette smoking and the risk
of childhood cancer among offspring of nonsmoking
mothers. J NatI Cancer Inst89:238-244 (1997).
58. Koo LC, Ho JH, Saw D, Ho CY. Measurements of passive
smoking and estimates of lung cancer risk among non-
smoking Chinese females. IntJ Cancer 39:162-169 (1987).
59. Pershagen G, Hrubec Z, Svensson C. Passive smoking
and lung cancer in Swedish women. Am J Epidemiol
125:17-24 (1987).
60. Shimizu H, Morishita M, Mizuno K, Masuda T, Ogura Y,
Santo M, Nishimura M, Kunishima K, Kanasawa K,
Nishiwaki K, et al. A case-control study of lung cancer in
nonsmoking women.Tohoku J Exp Med 154:389-397 (1988).
61. Janerich DT, Thompson WD, Varela LR, Greenwald P,
Chorost S, Tucci C, Zaman MB, Melamed MR, Kiely M,
McKneally MF. Lung cancer and exposure to tobacco
smoke in the household. N Engi J Med 323:632-636 (1990).
62. Sobue T. Association of indoor air pollution and lifestyle
with lung cancer in Osaka, Japan. Int J Epidemiol
19:S62-S66 (1990).
63. Brownson RC, Alavanja MCR, Hock ET, Loy TS. Passive
smoking and lung cancer in nonsmoking women. Am J
Public Health 82:1525-1530(1992).
64. Stockwell HG, Goldman AL, Lyman GH, Noss Cl, Armstrong
AW, Pinkham PA, Candelora EC, Brusa MR. Environmental
tobacco smoke and lung cancer risk in nonsmoking
women. J NatI Cancer Inst84:1417-1422 (1992).
65. Fontham ET, Correa P, Reynolds P, Wu-Williams A,
Buffler PA, Greenberg RS, Chen VW, Alterman T, Boyd P,
Austin DF, et al. Environmental tobacco smoke and lung
cancer in nonsmoking women: a multicenter study.
JAMA 271:1752-1759 (1994).
66. Kabat GC, Stellman SD, Wynder EL. Relation between
exposure to environmental tobacco smoke and lung can-
cer in lifetime nonsmokers. Am J Epidemiol 142:141-148
(1995).
67. Boffetta P, Agudo A, Ahrens W, Benhamou E, Benhamou
S, Darby SC, Ferro G, Fortes C, Gonzalez CA, Jockel KH,
et al. Multicenter case-control study of exposure to envi-
ronmental tobacco smoke and lung cancer in Europe. J
NatI Cancer Inst90:1440-1450 (1998).
68. Zaridze D, Maximovitch D, Zemlyanaya G, Aitakov ZN,
Boffetta P. Exposure to environmental tobacco smoke
and risk of lung cancer in non-smoking women from
Moscow, Russia. IntJ Cancer75:335-338 (1998).
69. Gold E, Gordis L, Tonascia J, Szklo M. Risk factors for
brain tumors in children. Am J Epidemiol 109:309-319
(1979).
70. Linet MS, Brookmeyer R. Use of cancer controls in case-
control cancer studies. Am J Epidemiol 125:1-11(1987).
71. Wilkins JR, Sinks T. Parental occupation and intracranial
neoplasms of childhood: results of a case-control inter-
view study. Am J Epidemiol 132:275-292 (1990).
72. Hemminki K, Saloniemi I, Salonen T, Partanen T, Vainio
H. Childhood cancer and parental occupation in Finland.
J Epidemiol Community Health 35:11-15 (1981).
73. Peters JM, Preston-Martin S, Yu MC. Brain tumors in
children and occupational exposure of parents. Science
213:235-237 (1981).
74. Harvey EB, Boice JD, Honeyman M, Flannery JT.
Prenatal X-ray exposure and childhood cancer in twins.
N EngI J Med 312:541-545 (1985).
75. Preston-Martin S. N-nitroso compounds as a cause of
human cancer. IARC Sci Publ 84: 477-484(1987).
76. Faggiano F, Partanen T, Kogevinas M, Boffetta P.
Socioeconomic differences in cancer incidence and
mortality. IARC Sci Publ 138:65-176 (1997).
77. Marsden HB. The classification of childhood tumours.
IARC Sci Publ 87:9-16 (1988).
78. Coghlin J, Gann PH, Hammond SK, Skipper PL,
Taghizadeh K, Paul M, Tannenbaum SR. 4-Aminobiphenyl
hemoglobin adducts in fetuses exposed to the tobacco
smoke carcinogen in utero. J NatI Cancer Inst 83:274-280
(1991).
79. Greenberg RA, Haley NJ, Etzel RA, Loda FA. Measuring
the exposure of infants to tobacco smoke. Nicotine and
cotinine in urine and saliva. N EngI J Med 310:1075-1078
(1984).
80. Etzel RA, Greenberg RA, Haley NJ, Loda FA. Urine coti-
nine excretion in neonates exposed to tobacco smoke
products in utero. J Pediatr 107:146-148 (1985).
81. Sorsa M, Husgafvel-Pursiainen K, Jarventaus H,
Koskimies K, Salo H, Vainio H. Cytogenetic effects of
tobacco smoke exposure among involuntary smokers.
Mutat Res 222:111-116(1989).
82. Jones AH, Fantel AG, Kocan RA, Juchau MR.
Bioactivation of procarcinogens to mutagens in human
fetal and placental tissues. Life Sci 21:1831-1836 (1977).
83. Everson RB, Randerath E, Santella RM, Cefalo RC, Avitts
TA, Randerath K. Detection of smoking-related covalent
DNA adducts in human placenta. Science 231:54-57
(1986).
84. Everson RB, Randerath E, Santella RM, Avitts TA,
Weinstein IB, Randerath K. Quantitative associations
between DNA damage in human placenta and maternal
smoking and birth weight. J NatI Cancer Inst 80:567-576
(1988).
85. Vessey MP. Epidemiological studies of the effects of
diethylstilboestrol. IARC Sci Publ 96:335-348 (1989).
86. Rice JM. Perinatal period and pregnancy: intervals of
high-risk for chemical carcinogens. Environ Health
Perspect29:23-27 (1979).
87. Tomatis L, Ponomarkov, Turusov V. The effect of ethyini-
trosourea administration during pregnancy on three sub-
sequent generations. lntJ Cancer 19:240-248 (1977).
88. U.S. Department of Health and Human Services. The
Health Consequences of Smoking for Women. A Report
of the Surgeon General. Washington, DC:Office of the
Assistant Secretary for Health, Office on Smoking and
Health, 1980.
Environmental Health
Perspectives online at the
Enviropmental H
form ervice
I
82 Volume 108, Number 1, January 2000 * Environmental Health Perspectives